Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTP4A1 | Q93096 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.67 |
| ▸ | PKM | P14618 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 7/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | PTP4A3 | O75365 | 2/20 | 0.61 |
| ▸ | PTP4A2 | Q12974 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.51 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5618664 | 1.00 | PTP4A1 (0.70) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL2215142 | 0.91 | ALDH1A1 (0.74) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL27446825 | 0.88 | PTP4A1 (0.81) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL27441085 | 0.87 | PTP4A1 (0.59) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL27441080 | 0.87 | PTP4A1 (0.59) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL27441062 | 0.87 | PTP4A1 (0.59) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL27441069 | 0.87 | PTP4A1 (0.59) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL23530140 | 0.84 | ALDH1A1 (0.75) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL2211505 | 0.84 | ALDH1A1 (0.75) | PTP4A1ALDH1A1PKMHTTMAPT | |
| SCHEMBL10678680 | 0.83 | ALDH1A1 (0.73) | PTP4A1ALDH1A1PKMHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-11325901-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2022-05-10 | — | — | US | disclosed |
| US-11220497-B2 | — | — | 2022-01-11 | — | — | US | disclosed |
| US-20200231583-A1 | Prostaglandin E Synthase Inhibitors and Methods for Utilizing the Same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2020-07-23 | — | — | US | disclosed |
| US-7235674-B2 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. (US) | 2007-06-26 | — | — | US | disclosed |
| US-7015328-B2 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. (US) | 2006-03-21 | — | — | US | disclosed |
| US-20050090526-A1 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. (US) | 2005-04-28 | — | — | US | disclosed |
| EP-1392283-A4 | SUBSTITUTED COUMARINS AND QUINOLINES AS CASPASE ACTIVATORS | CYTOVIA INC (US) | 2004-10-20 | — | — | EP | disclosed |
| EP-1392283-A1 | SUBSTITUTED COUMARINS AND QUINOLINES AS CASPASES ACTIVATORS | Cytovia, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20030114485-A1 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2003-06-19 | — | — | US | disclosed |
| WO-2002092076-A1 | SUBSTITUTED COUMARINS AND QUINOLINES AS CASPASES ACTIVATORS | CYTOVIA, INC. (US) | 2002-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325901-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | PTGES, PTGS1, PTGES2 | PTP4A1 1444/4885ALDH1A1 474/4885PKM 1506/4885 |
| US-11220497-B2 | — | PTGES, PTGS1, PTGES2 | PTP4A1 1630/4885ALDH1A1 551/4885PKM 1098/4885 |
| US-20030114485-A1 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof | CASP7, CASP1, CASP5 | PTP4A1 2068/4885ALDH1A1 1275/4885PKM 3283/4885 |
| US-20200231583-A1 | Prostaglandin E Synthase Inhibitors and Methods for Utilizing the Same | PTGES, PTGS1, PTGES2 | PTP4A1 1444/4885ALDH1A1 474/4885PKM 1506/4885 |
| US-20050090526-A1 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof | CASP7, CASP5, CASP14 | PTP4A1 2487/4885ALDH1A1 1656/4885PKM 2984/4885 |
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | PTGES, PTGS1, PTGES2 | PTP4A1 1444/4885ALDH1A1 474/4885PKM 1506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.